Endometrium kanserinde preoperatif görüntüleme bulgularıyla nihai patolojinin karşılaştırılması

Year 2024, Volume: 17 Issue: 3, 341 - 350, 20.12.2024

Özcan Yılmaz , Görkem Ülger , Ali Yıldızbakan , Hasan Hüsnü Yüksek , Hakan Aytan , Şevki Göksun Gökulu

https://izlik.org/JA45LG88BA

Abstract

Amaç: Bu çalışmada preoperatif görüntülemesi yapılmış olan endometrium kanserli hastaların görüntüleme sonuçlarıyla postoperatif nihai patoloji sonuçlarını retrospektif olarak karşılaştırmayı amaçladık. Yöntem: 1 Ocak 2019 - 4 Ağustos 2022 tarihleri arasında Mersin Üniversitesi Tıp Fakültesi Hastanesi Kadın Hastalıkları ve Doğum Anabilim Dalı Jinekoloji-Onkoloji polikliniğinde takip ve tedavi edilen preoperatif görüntülemesi olan toplam 123 endometrium kanserli kadın hasta çalışmaya dâhil edilmiştir. Hastaların preoparetif görüntüleme sonuçları ve nihai patoloji sonuçları karşılaştırılmıştır. Bulgular: Preoperatif 10 MRG, 67 BT, 46 PET/BT görüntülemesi olan hastaların nihai patoloji sonuçlarıyla yapılan karşılaştırmalar sonucunda görüntülemenin çalışmamızda bulduğumuz sensitivite değeri literatürden düşük olup, lenf nodu metastazı ve uzak metastaz açısından PET/BT’nin sensitivite, spesifite, pozitif ve negatif prediktif değerleri MRG ve BT’ye kıyasla daha yüksek bulunmuştur. Ayrıca çalışmamızda ameliyat öncesi görüntüleme yöntemleri ile pelviste tespit edilen en büyük lenf nodu boyutunun 15.5 mm ve üzeri olmasının, pelviste lenf nodu metastazı varlığını %60 sensitivite ve %70,8 spesifisite ile öngörebildiği bulunmuştur. Sonuç: Endometrium kanserinde uterus dışına yayılmış hastalık varlığında PET/BT görüntülemenin hastaların operasyon öncesi lenf nodu tutulumunu göstermede, klinik evresinin tespitinde ve operasyonun şeklinin ve genişliğinin belirlenmesinde önemli yeri vardır. Ayrıca çalışmamızda bulduğumuz pelvik lenf nodu metastazı açısından görüntülemedeki pelvik lenf nodu boyutu cut-off değeri yapılacak klinik evrelemede klinisyenlere yol gösterebilir.

Keywords

Endometrium kanseri , patoloji , preoparetif görüntüleme

Comparison of preoperative imaging findings and final postoperative pathology in endometrium cancer

https://izlik.org/JA45LG88BA

Abstract

Aim: In this study, we aimed to retrospectively compare the imaging results of patients with endometrial cancer who underwent preoperative imaging with the final postoperative pathology results. Method: A total of 123 female patients with endometrial cancer with preoperative imaging were followed and treated in the Gynecology-Oncology outpatient clinic of the Department of Obstetrics and Gynecology, Mersin University Faculty of Medicine Hospital between 1 January 2019 and 4 August 2022 were included in the study. Preoperative imaging results and final pathology results were compared. Results: As a result of comparisons with the final pathology results of patients with preoperative 10 MRI, 67 CT, and 46 PET/CT imaging, the sensitivity value of imaging was lower than the literature, but the sensitivity, specificity, positive and negative predictive values of PET/CT were higher in terms of lymph node metastasis and distant metastasis compared to MRI and CT. In addition, our study found that the largest lymph node size of 15.5 mm or more detected by preoperative imaging methods in the pelvis predicted the presence of lymph node metastasis in the pelvis with a sensitivity of 60% and a specificity of 70.8%. Conclusion: In endometrial cancer, PET/CT imaging has an essential role in showing preoperative lymph node involvement, determining the clinical stage, and determining the type and extent of the operation in the presence of disease spread outside the uterus. In addition, the cut-off value of pelvic lymph node size in imaging for pelvic lymph node metastasis found in our study may guide clinicians in clinical staging.

Keywords

Endometrial cancer , pathology , preoperative imaging

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249.
• Seagle BLL, Alexander AL, Lantsman T, Shahabi S. Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database. Am J Obstet Gynecol. 2018;218(3):329-e1.
• Ma J, Zhou C, Chen J, Chen X. Prognosis and efficacy of laparoscopic surgery on patients with endometrial carcinoma: systematic evaluation and meta-analysis. Comput Math Methods Med. 2022;2022.
• Reijntjes B, van Suijlichem M, Woolderink JM, et al. Recurrence and survival after laparoscopy versus laparotomy without lymphadenectomy in early-stage endometrial cancer: long-term outcomes of a randomised trial. Gynecol Oncol. 2022;164(2):265-270.
• Raffone A, Travaglino A, Raimondo D, et al. Laparotomic versus robotic surgery in elderly patients with endometrial cancer: A systematic review and meta‐analysis. International Journal of Gynecology & Obstetrics. 2022;157(1):1-10.
• Li XM, Wang J. Comparison of robotic surgery with laparoscopy for surgical staging of endometrial cancer: a meta-analysis. Zhonghua Fu Chan Ke Za Zhi. 2017;52(3):175-183.
• Cao S yu, Fan Y, Zhang Y fei, Ruan J ying, Mu Y, Li J ke. Recurrence and survival of patients with stage III endometrial cancer after radical surgery followed by adjuvant chemo-or chemoradiotherapy: a systematic review and meta-analysis. BMC Cancer. 2023;23(1):31.
• Zhang G, Li H, Tian Z, et al. Adjuvant chemoradiotherapy versus chemotherapy alone in stage III endometrial cancer: A systematic review and meta‐analysis. Journal of Obstetrics and Gynaecology Research. 2022;48(7):1888-1896.
• Kinkel K, Kaji Y, Yu KK, et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology. 1999;212(3):711-718.
• Delso G, Fürst S, Jakoby B, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. Journal of nuclear medicine. 2011;52(12):1914-1922.
• Antonsen SL, Jensen LN, Loft A, et al. MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer—a multicenter prospective comparative study. Gynecol Oncol. 2013;128(2):300-308.
• Teng F, Zhang Y, Wang Y, et al. Contrast‐enhanced MRI in preoperative assessment of myometrial and cervical invasion, and lymph node metastasis: Diagnostic value and error analysis in endometrial carcinoma. Acta Obstet Gynecol Scand. 2015;94(3):266-273.
• Bi Q, Chen Y, Wu K, et al. The diagnostic value of MRI for preoperative staging in patients with endometrial cancer: a meta-analysis. Acad Radiol. 2020;27(7):960-968.
• Yılmaz A, Yılmaz F, Şahin HÖ, Atalay FÖ, Uysal D, Ozan H. Comparing the efficacy of imaging techniques in detecting myometrial invasion, cervical involvement and pelvic lymph-nodal metastasis in endometrial cancer. Ege Tıp Dergisi. 2022;61(4):647-650.
• Sallée C, Margueritte F, Gouy S, et al. FDG-PET/CT and para-aortic staging in endometrial cancer. A French multicentric study. J Clin Med. 2021;10(8):1746.
• Kitajima K, Suzuki K, Senda M, et al. Preoperative nodal staging of uterine cancer: is contrast-enhanced PET/CT more accurate than non-enhanced PET/CT or enhanced CT alone? Ann Nucl Med. 2011;25:511-519.
• Atri M, Zhang Z, Dehdashti F, et al. Utility of PET/CT to evaluate retroperitoneal lymph node metastasis in high-risk endometrial cancer: results of ACRIN 6671/GOG 0233 trial. Radiology. 2017;283(2):450-459.
• Mayoral M, Paredes P, Domènech B, et al. 18F-FDG PET/CT and sentinel lymph node biopsy in the staging of patients with cervical and endometrial cancer. Role of dual-time-point imaging. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 2017;36(1):20-26.
• Bollineni VR, Ytre-Hauge S, Bollineni-Balabay O, Salvesen HB, Haldorsen IS. High diagnostic value of 18F-FDG PET/CT in endometrial cancer: systematic review and meta-analysis of the literature. Journal of Nuclear Medicine. 2016;57(6):879-885.
• Gee MS, Atri M, Bandos AI, Mannel RS, Gold MA, Lee SI. Identification of distant metastatic disease in uterine cervical and endometrial cancers with FDG PET/CT: analysis from the ACRIN 6671/GOG 0233 multicenter trial. Radiology. 2018;287(1):176-184.
• Crivellaro C, Landoni C, Elisei F, et al. Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients. International Journal of Gynecologic Cancer. 2020;30(3).
• Taşkin S, Varli B, Ersöz CC, Altin D, Soydal Ç, Ortaç F. Complementary role of 18F-FDG PET/CT for sentinel lymph node algorithm in endometrial cancer with high-risk factors for lymphatic metastasis. Nucl Med Commun. 2020;41(4):389-394.
• Inubashiri E, Hata K, Kanenishi K, et al. Positron emission tomography with the glucose analog [18F]‐fluoro‐2‐deoxy‐D‐glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: Comparison with CT and MRI findings. Journal of Obstetrics and Gynaecology Research. 2009;35(1):26-34.